{
    "title": "Texas abortion pill ruling could undermine US drug regulator",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11956419/Texas-abortion-pill-ruling-undermine-US-drug-regulator.html",
    "date": "2023-04-10",
    "keywords": [
        "fda",
        "drug",
        "ruling",
        "approval",
        "mifepristone",
        "health",
        "safety",
        "decision",
        "policy",
        "friday",
        "case",
        "impact",
        "kacsmaryk",
        "week",
        "food",
        "agency",
        "district",
        "antiabortion",
        "industry",
        "government",
        "process",
        "research",
        "development",
        "challenge",
        "order",
        "ban",
        "court",
        "possibility",
        "uncertainty",
        "washington",
        "abortion",
        "pill",
        "judge",
        "matthew",
        "kacsmaryks",
        "march",
        "hearing",
        "injunction",
        "texas",
        "part",
        "half",
        "sale",
        "question",
        "power",
        "bet",
        "disaster",
        "lassman",
        "lawyer",
        "experience",
        "law",
        "access",
        "alliance",
        "medicine",
        "v",
        "administration",
        "coalition",
        "withdrawal",
        "activist",
        "market",
        "chance",
        "emergency",
        "appeal",
        "finding",
        "status",
        "arbiter",
        "ability",
        "secure",
        "something",
        "sobel",
        "associate",
        "director",
        "family",
        "foundation",
        "age",
        "pregnancy",
        "america",
        "phrma",
        "biotechnology",
        "innovation",
        "organization",
        "authority",
        "secretary",
        "becerra",
        "cnn",
        "proper",
        "confidence",
        "become",
        "partner",
        "life",
        "group",
        "practice",
        "scrutiny",
        "place",
        "lee",
        "pricing",
        "level",
        "risk",
        "activism",
        "lobbying",
        "covid19"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}